Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
4
×
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
sanofi
4
×
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
boston top stories
clinical trials
europe blog main
europe top stories
fda
allergan
biofourmis
cancer
cancer immunotherapy
chronic kidney disease
covid-19
crispr
What
bio
roundup
abbvie’s
acquisitions
ahead
announced
biofourmis
black
bucks
cancer
celebrate
ceo
chance
cholesterol
collabs
companies
continue
corner
covid
daniel
day
days
deal
debut
diamond
diamond’s
drug
drugs
expensive
faces
financial
foe
forward
gilead
gilead’s
healthcare
help
hint
holiday
indication
Language
unset
4
×
Current search:
sanofi
×
national
×
unset
×
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)
